Pfizer (PFE) Pension (2009 - 2026)

Pfizer (PFE) has reported Pension for 18 consecutive years, with $1.9 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Pension fell 9.06% year-over-year to $1.9 billion in Q2 2026; TTM through Jun 2026 was $1.9 billion, a 9.06% decrease from a year earlier, with the FY2025 full-year figure at $2.0 billion, down 3.5% from the prior year.
• Pension was $1.9 billion for Q2 2026 at Pfizer, down from $2.0 billion in the prior quarter.
• Over five years, Pension peaked at $3.3 billion in Q2 2022 and troughed at $1.9 billion in Q2 2026.
• A 5-year average of $2.2 billion and a median of $2.1 billion in 2024 frame the typical range for Pension.
• Across the five-year window, Pension plunged 39.58% in 2022 and increased 4.41% in 2025, its largest moves.
• Over 5 years, Pension stood at $2.2 billion in 2022, then slipped by 3.69% to $2.2 billion in 2023, then declined by 2.4% to $2.1 billion in 2024, then dropped by 3.5% to $2.0 billion in 2025, then decreased by 5.1% to $1.9 billion in 2026.
• The last three Pension figures came in at $1.9 billion (Q2 2026), $2.0 billion (Q1 2026), and $2.0 billion (Q4 2025), per Business Quant data.